Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study

Tinzaparin could be easier to manage than unfractionated heparin in patients with severe renal impairment. However, clinical and pharmacologic data regarding its use in such patients are lacking. The aims of this study were to determine, in patients with estimated glomerular filtration rate (eGFR) o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thrombosis and haemostasis 2024-10, Vol.22 (10), p.2864-2872
Hauptverfasser: Gouin-Thibault, Isabelle, Mansour, Alexandre, Caribotti, Charlène, Pierre-Jean, Morgane, Bouzille, Guillaume, Ballerie, Alice, Maucorps, Laure, Gueret, Pierre, Nédelec-Gac, Fabienne, Pontis, Adeline, Mahé, Guillaume, Vannier, Stéphane, Behar, Nathalie, Cardiet, Isabelle, Mismetti, Patrick, Frouget, Thierry, Delavenne, Xavier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Tinzaparin could be easier to manage than unfractionated heparin in patients with severe renal impairment. However, clinical and pharmacologic data regarding its use in such patients are lacking. The aims of this study were to determine, in patients with estimated glomerular filtration rate (eGFR) of
ISSN:1538-7836
1538-7836
DOI:10.1016/j.jtha.2024.07.006